Authors:
Nejat, RJ
Purohit, R
Goluboff, ET
Petrylak, D
Rubin, MA
Benson, MC
Citation: Rj. Nejat et al., Cure of undifferentiated small cell carcinoma of the urinary bladder with M-VAC chemotherapy, UROL ONCOL, 6(2), 2001, pp. 53-55
Authors:
Ghafar, MA
Johnson, CW
De La Taille, A
Benson, MC
Bagiella, E
Fatal, M
Olsson, CA
Katz, AE
Citation: Ma. Ghafar et al., Salvage cryotherapy using an argon based system for locally recurrent prostate cancer after radiation therapy: The Columbia experience, J UROL, 166(4), 2001, pp. 1333-1337
Authors:
De la Taille, A
Benson, MC
Bagiella, E
Burchardt, M
Shabsigh, A
Olsson, CA
Katz, AE
Citation: A. De La Taille et al., Cryoablation for clinically localized prostate cancer using an argon-basedsystem: complication rates and biochemical recurrence, BJU INT, 85(3), 2000, pp. 281-286
Authors:
Lee, N
Fawaaz, R
Olsson, CA
Benson, MC
Petrylak, DP
Schiff, PB
Bagiella, E
Singh, A
Ennis, RD
Citation: N. Lee et al., Which patients with newly diagnosed prostate cancer need a radionuclide bone scan? An analysis based on 631 patients, INT J RAD O, 48(5), 2000, pp. 1443-1446
Authors:
Choi, J
Shendrik, I
Peacocke, M
Peehl, D
Buttyan, R
Ikeguchi, EF
Katz, AE
Benson, MC
Citation: J. Choi et al., Expression of senescence-associate beta-galactosidase in enlarged prostates from men with benign prostatic hyperplasia, UROLOGY, 56(1), 2000, pp. 160-166
Authors:
de la Taille, A
Hayek, O
Benson, MC
Bagiella, E
Olsson, CA
Fatal, M
Katz, AE
Citation: A. De La Taille et al., Salvage cryotherapy for recurrent prostate cancer after radiation therapy:The Columbia experience, UROLOGY, 55(1), 2000, pp. 79-84
Authors:
Nejat, RJ
Rashid, HH
Bagiella, E
Katz, AE
Benson, MC
Citation: Rj. Nejat et al., A prospective analysis of time to normalization of serum testosterone after withdrawal of androgen deprivation therapy, J UROL, 164(6), 2000, pp. 1891-1894
Authors:
Ennis, RD
Petrylak, DP
Singh, P
Bagiella, E
O'Toole, KM
Benson, MC
Olsson, CA
Citation: Rd. Ennis et al., The effect of cystectomy, and perioperative methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy on the risk and pattern of relapse in patients with muscle invasive bladder cancer, J UROL, 163(5), 2000, pp. 1413-1418
Citation: Mc. Benson, Neo-adjuvant chemotherapy and bladder preservation in locally advanced transitional cell carcinoma of the bladder, ANN ONCOL, 10(11), 1999, pp. 1269-1270
Citation: Mc. Benson, Total and transition zone prostate volume and age: How do they affect the utility of PSA-based diagnostic parameters for early prostate cancer detection? Editorial comment, UROLOGY, 54(5), 1999, pp. 852-852
Authors:
Lee, N
Newhouse, JH
Olsson, CA
Benson, MC
Petrylak, DP
Schiff, PB
Bagiella, E
Malyszko, B
Ennis, RD
Citation: N. Lee et al., Which patients with newly diagnosed prostate cancer need a computed tomography scan of the abdomen and pelvis? An analysis based on 588 patients, UROLOGY, 54(3), 1999, pp. 490-494
Authors:
De la Taille, A
Olsson, CA
Buttyan, R
Benson, MC
Bagiella, E
Cao, Y
Burchardt, M
Chopin, DK
Katz, AE
Citation: A. De La Taille et al., Blood-based reverse transcriptase polymerase chain reaction assays for prostatic specific antigen: Long term follow-up confirms the potential utilityof this assay in identifying patients more likely to have biochemical recurrence (rising PSA) following radical prostatectomy, INT J CANC, 84(4), 1999, pp. 360-364